Shenzhen Rentai Pharmatech Ltd

Huawei Technologies Co., Limited

Shenzhen Jingtai Technology Co., Ltd.

Jiajun Huang

Wei Zhang

Dongxu Yi

Guobin Ren

Weijie Ji

Jinbo Ma

Zuqi Liu

Jianfeng Zheng

Yang Liu

Jian Ma

Shuhao Wen

Peiyu Zhang

Guangxu Sun

Mingjun Yang

Xuekun Shi

Yanqi Zhang

Shigang Ruan

A crystalline form A of 2,2-bis(4-fluorophenyl)-2-phenylacetamide is provided. The crystalline form has good light stability, high temperature stability, and high humidity stability.

Crystalline form a of 2, 2-bis(4-fluorophenyl)-2-phenylacetamide and preparation method therefor and application thereof

Disclosed are eutectic form A of Elagolix and pyrimethamine, a preparation method therefor and a use thereof. Using Cu-Kα radiation, eutectic form A has characteristic peaks represented by a 2θ degree at 8.1±0.2°, 12.2±0.2°, 13.3±0.2° and 21.1±0.2° in an X-ray powder diffraction. Eutectic form A has a high purity, a good light radiation stability, a high temperature stability, a high humidity stability and an accelerated stability, is easy to store, and has a slow moisture absorption under the condition of relatively low humidity, wherein the weight gain of eutectic form A by moisture absorption is not more than 1.08% when the relative humidity increases from 0 to 60% RH. Production conditions for eutectic form A are easy to control, same has a simple preparation process and a stable quality, and is easy to industrially produce on a large-scale.

Eutectic form A of Elagolix and pyrimethamine, preparation method therefor and use thereof

Provided is crystal form A of N,N'-(10,17-dioxo-3,6,21,24-tetraoxa-9,11,16, 18-tetrazohexahexane-1,26-di-yl)bis(4-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline-4-yl) benzene sulfonamide. The crystal form has good light stability, high-temperature stability, and high-humidity stability.

Crystal form a of NHE3 inhibitor, preparation method therefor and application thereof

A crystal form X of 3α-hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one, a preparation method of said crystal form and an application thereof in preparing a drug for treatment of central nervous system disease.

γ-aminobutyric acid modulator crystal form X, preparation method and application thereof

A vehicle braking energy recovering method includes obtaining current location information of a vehicle, determining a current road scenario based on the current location information of the vehicle, determining the current road scenario based on a mapping relationship between a road scenario and a weight, determining a safe distance and a safe speed of the vehicle based on the weight, determining a target torque based on the safe distance and the safe speed of the vehicle, and controlling, based on the target torque, a motor of the vehicle to recover braking energy.

Vehicle braking energy recovering method and apparatus

Vehicle breaking energy recovering method and apparatus

Forms B and C of (R)&#x2014;N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide are stable under the conditions of light, high temperature and high humidity.

Forms of (R)-N-(4-chlorophenyl)-2-(cis-4-(6-fluoroquinolin-4- yl)cyclohexyl)propanamide

Growing community of inventors

Shenzhen, China

Jiajun Huang